Status:
ACTIVE_NOT_RECRUITING
Anti-inflammatory Probiotics in Cognitive Functioning
Lead Sponsor:
University of Social Sciences and Humanities, Warsaw
Collaborating Sponsors:
Sanprobi Sp. z o. o.
National Science Centre, Poland
Conditions:
Memory Decline
Cognitive Decline
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The goal of this study is to explore the potential impact of an anti-inflammatory probiotic mixture of psychobiotics including Bifidobacterium longum Rosell®-175 and Lactobacillus helveticus Rosell®-5...
Eligibility Criteria
Inclusion
- Aged 50 or older
- Signed written Informed Consent Form
- Score ≥28 on the Mini-Mental State Examination (MMSE)
- A willingness and motivation to follow the study protocol
Exclusion
- Regular use of prebiotics, antibiotics, or antifungal medications
- Use of prebiotics, antibiotics, or antifungal medications within the past 3 months
- Diagnosed neurological disorder
- History of head injury with neurological consequences
- Left-handedness
Key Trial Info
Start Date :
January 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT07165977
Start Date
January 25 2024
End Date
December 31 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SWPS University
Warsaw, Masovian Voivodeship, Poland, 03-815